ENCELTO Trademark

Trademark Overview


On Wednesday, January 4, 2023, a trademark application was filed for ENCELTO with the United States Patent and Trademark Office. The USPTO has given the ENCELTO trademark a serial number of 97741367. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, April 3, 2026. This trademark is owned by Neurotech Pharmaceuticals, Inc.. The ENCELTO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical device, namely, intraocular implant

Intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions
encelto

General Information


Serial Number97741367
Word MarkENCELTO
Filing DateWednesday, January 4, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, April 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2024

Trademark Statements


Goods and ServicesMedical device, namely, intraocular implant
Goods and ServicesIntravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2023
Primary Code005
First Use Anywhere DateWednesday, June 4, 2025
First Use In Commerce DateWednesday, June 4, 2025

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2023
Primary Code010
First Use Anywhere DateWednesday, June 4, 2025
First Use In Commerce DateWednesday, June 4, 2025

Trademark Owner History


Party NameNeurotech Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCumberland, RI 02864
US

Party NameNeurotech Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCumberland, RI 02864
US

Trademark Events


Event DateEvent Description
Saturday, January 7, 2023NEW APPLICATION ENTERED
Saturday, January 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 27, 2023ASSIGNED TO EXAMINER
Wednesday, September 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 26, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 26, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, March 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, December 12, 2024SOU EXTENSION 1 FILED
Friday, December 13, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 25, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 25, 2025SOU EXTENSION 2 FILED
Wednesday, June 25, 2025SOU EXTENSION 2 GRANTED
Thursday, June 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2025TEAS STATEMENT OF USE RECEIVED
Friday, April 3, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 7, 2025USE AMENDMENT FILED
Friday, April 3, 2026STATEMENT OF USE PROCESSING COMPLETE